PDS Biotechnology Corp — Director's Dealing 2025

Mar 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PDS Biotechnology Corp (PDSB)
CIK: 0001472091
Period of Report: 2025-02-28

Reporting Person: Freitag Gregory Gene (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-28	Common Stock	P	15060	$1.66	Acquired	61213	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-28	Common Warrant	$1.53	P	15060	Acquired	2030-02-28	Common Stock (15060)	Direct

Footnotes

F1: The purchase price for the Common Warrant is included in the purchase price for the shares of Common Stock reflected in Table I above.